Cargando…

Correction of the coagulation defect in hemophilia using a factor Xa variant with novel engineered protease function

Effective therapies are needed to control excessive bleeding in a range of clinical conditions. We describe a surprisingly useful approach to improve hemostasis in vivo using a variant of coagulation factor Xa (FXa(I16L)). This conformationally pliant derivative is partially inactive due to a defect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ivanciu, Lacramioara, Toso, Raffaella, Margaritis, Paris, Pavani, Giulia, Kim, Haein, Schlachterman, Alexander, Liu, Jian-Hua, Clerin, Valerie, Pittman, Debra D., Rose-Miranda, Rosalind, Shields, Kathleen M., Erbe, David V., Tobin, James F., Arruda, Valder R., Camire, Rodney M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157830/ https://www.ncbi.nlm.nih.gov/pubmed/22020385 http://dx.doi.org/10.1038/nbt.1995

Ejemplares similares

Microfluidic hemophilia models using blood from healthy donors
por: Yu, Xinren, et al.
Publicado: (2019)

Protein-Engineered Coagulation Factors for Hemophilia Gene Therapy
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2018)

Coagulation Factor Xa
por: Brown, Mark A., et al.
Publicado: (2013)

Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
por: Arruda, Valder R., et al.
Publicado: (2020)

Roles of factor Xa beyond coagulation
por: Ruf, Wolfram
Publicado: (2021)

Emerging therapies for hemophilia: controversies and unanswered questions
por: Arruda, Valder R., et al.
Publicado: (2018)

Profile of efraloctocog alfa and its potential in the treatment of hemophilia A
por: George, Lindsey A, et al.
Publicado: (2015)

Translational Potential of Immune Tolerance Induction by AAV Liver-Directed Factor VIII Gene Therapy for Hemophilia A
por: Samelson-Jones, Benjamin J., et al.
Publicado: (2020)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα
por: Ayombil, Francis, et al.
Publicado: (2022)

Procoagulant Adaptation of a Blood Coagulation Prothrombinase-like Enzyme Complex in Australian Elapid Venom
por: Bos, Mettine H.A., et al.
Publicado: (2010)

Characteristics of BAY 2599023 in the Current Treatment Landscape of Hemophilia A Gene Therapy
por: Pipe, Steven W., et al.
Publicado: (2023)

Coagulation Factor IX for Hemophilia B Therapy 
por: Orlova, N. A., et al.
Publicado: (2012)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs
por: Callan, Mary Beth, et al.
Publicado: (2016)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Antiplatelet Aggregation Properties of Cirsilineol: A Novel Inhibitor of Blood Coagulation Factor Xa
por: Kim, Go Oun, et al.
Publicado: (2023)

Utilization Patterns of Coagulation Factor Consumption for Patients with Hemophilia
por: Lee, Soo Ok, et al.
Publicado: (2016)

Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa
por: Maag, Anja, et al.
Publicado: (2021)

Thermodynamics of Water in an Enzyme Active Site: Grid-Based Hydration Analysis of Coagulation Factor Xa
por: Nguyen, Crystal N., et al.
Publicado: (2014)

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
por: Posthuma, Jelle J., et al.
Publicado: (2019)

Differential Assessment of Factor Xa Activity and Global Blood Coagulability Utilizing Novel Dielectric Coagulometry
por: Hamada, Satomi, et al.
Publicado: (2018)

Coagulation Factor Xa Promotes Solid Tumor Growth, Experimental Metastasis and Endothelial Cell Activation
por: Arce, Maximiliano, et al.
Publicado: (2019)

Molecular Dynamics Simulation Study of the Selective Inhibition of Coagulation Factor IXa over Factor Xa
por: Yoon, Hyun Jung, et al.
Publicado: (2023)

STUDIES ON BLOOD COAGULATION : IV. THE NATURE OF THE CLOTTING DEFICIENCY IN HEMOPHILIA
por: Eagle, Harry
Publicado: (1935)

B cell–activating factor modulates the factor VIII immune response in hemophilia A
por: Doshi, Bhavya S., et al.
Publicado: (2021)

Blood flow controls coagulation onset via the positive feedback of factor VII activation by factor Xa
por: Shibeko, Alexey M, et al.
Publicado: (2010)

Rivaroxaban‐calibrated chromogenic anti‐Xa assay in cirrhosis: Use to rule out disseminated intravascular coagulation
por: Lucas, Fabienne, et al.
Publicado: (2021)

Parallel imaging of coagulation pathway proteases activated protein C, thrombin, and factor Xa in human plasma
por: Modrzycka, Sylwia, et al.
Publicado: (2022)

Factor V has an anticoagulant cofactor activity that targets the early phase of coagulation
por: Santamaria, Salvatore, et al.
Publicado: (2017)

Toward non-factor therapy in hemophilia: an antithrombin insensitive Gla-domainless factor Xa as tissue factor pathway inhibitor bait
por: Dagher, Marie-Claire, et al.
Publicado: (2023)

Global coagulation assays in hemophilia A: A comparison to conventional assays
por: Aghighi, Saman, et al.
Publicado: (2019)

Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy
por: Mast, Alan E., et al.
Publicado: (2022)

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
por: Moon, Byung Suk, et al.
Publicado: (2013)

The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm
por: Borensztajn, Keren, et al.
Publicado: (2010)

Author Correction: Differential Assessment of Factor Xa Activity and Global Blood Coagulability Utilizing Novel Dielectric Coagulometry
por: Hamada, Satomi, et al.
Publicado: (2019)

Protein‐Templated Formation of an Inhibitor of the Blood Coagulation Factor Xa through a Background‐Free Amidation Reaction
por: Jaegle, Mike, et al.
Publicado: (2017)

The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents
por: Frydman, Galit H., et al.
Publicado: (2020)

Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial
por: Baker, Jason V, et al.
Publicado: (2020)

Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1
por: D’Alessandro, Elisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_icp8e9ekbv8je7ctoejp4i5mhu